Transfusion Reactions. Newer Concepts on the Pathophysiology, Incidence, Treatment, and Prevention of Transfusion-Related Acute Lung Injury

Critical Care Clinics

Volumn 28, Issue 3, 2012, Pages 363-372

  Sayah, David M ^a   Looney, Mark R ^a   Toy, Pearl ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute lung injury; Multiple transfusions; Pulmonary edema; Transfusion reaction; Transfusion related acute lung injury

Indexed keywords

ANTIBODY; BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; HLA ANTIBODY; HLA CLASS 2 ANTIBODY; HUMAN LEUKOCYTE ANTIGEN ANTIBODY; HUMAN NEUTROPHIL ANTIGEN ANTIBODY; INFUSION FLUID; INTERLEUKIN 8; PROTEIN; UNCLASSIFIED DRUG;

ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CLINICAL FEATURE; DISEASE PREDISPOSITION; DRUG CONTRAINDICATION; ECHOCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; HUMAN; INCIDENCE; LEUKOCYTE COUNT; LUNG FLUID; NONHUMAN; OXYGEN THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMA TRANSFUSION; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; RISK FACTOR; SEX DIFFERENCE; THROMBOCYTE ACTIVATION; THROMBOCYTE TRANSFUSION; TRANSFUSION RELATED ACUTE LUNG INJURY;

ACUTE LUNG INJURY; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; HUMANS; INCIDENCE; RISK FACTORS;

EID: 84862543603     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2012.04.001     Document Type: Review

References (54)

1. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2009. Annual Summaries 2010 Accessed February 2, 2011. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm204763.htm.
2. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149(3 Pt 1):818-824.
3. Kleinman S., Caulfield T., Chan P., et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004, 44(12):1774-1789.
4. Toy P., Popovsky M.A., Abraham E., et al. Transfusion-related acute lung injury: Definition and review. Crit Care Med 2005, 33(4):721-726.
5. Fowler A.A., Hamman R.F., Good J.T., et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 1983, 98(5 Pt 1):593-597.
6. Popovsky M.A., Abel M.D., Moore S.B. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983, 128(1):185-189.
7. Popovsky M.A., Moore S.B. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985, 25(6):573-577.
8. Toy P., Gajic O., Bacchetti P., et al. Transfusion related acute lung injury: incidence and risk factors. Blood 2012, 119(7):1757-1767.
9. Rubenfeld G.D., Caldwell E., Peabody E., et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353(16):1685-1693.
10. Looney M.R., Su X., Van Ziffle J.A., et al. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006, 116(6):1615-1623.
11. Sachs U.J., Hattar K., Weissmann N., et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood 2006, 107(3):1217-1219.
12. Sachs U.J., Wasel W., Bayat B., et al. Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies. Blood 2011, 117(2):669-677.
13. Strait R.T., Hicks W., Barasa N., et al. MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice. J Exp Med 2011, 208(12):2525-2544.
14. Looney M.R., Nguyen J.X., Hu Y., et al. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest 2009, 119(11):3450-3461.
15. Hidalgo A., Chang J., Jang J.E., et al. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med 2009, 15(4):384-391.
16. Silliman C.C., Voelkel N.F., Allard J.D., et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998, 101(7):1458-1467.
17. Silliman C.C., Bjornsen A.J., Wyman T.H., et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003, 43(5):633-640.
18. Silliman C.C., Clay K.L., Thurman G.W., et al. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994, 124(5):684-694.
19. Vlaar A.P., Hofstra J.J., Determann R.M., et al. The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood 2011, 117(16):4218-4225.
20. Silliman C.C., Moore E.E., Kelher M.R., et al. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 2011, 51(12):2549-2554.
21. Silliman C.C., Paterson A.J., Dickey W.O., et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997, 37(7):719-726.
22. Triulzi D.J., Kleinman S., Kakaiya R.M., et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009, 49(9):1825-1835.
23. Kopko P.M., Popovsky M.A., MacKenzie M.R., et al. HLA class II antibodies in transfusion-related acute lung injury. Transfusion 2001, 41(10):1244-1248.
24. Reil A., Keller-Stanislawski B., Gunay S., et al. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008, 95(4):313-317.
25. Chapman C.E., Stainsby D., Jones H., et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009, 49(3):440-452.
26. Gajic O., Rana R., Winters J.L., et al. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007, 176(9):886-891.
27. Bierling P., Bux J., Curtis B., et al. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang 2009, 96(3):266-269.
28. Dykes A., Smallwood D., Kotsimbos T., et al. Transfusion-related acute lung injury (Trali) in a patient with a single lung transplant. Br J Haematol 2000, 109(3):674-676.
29. Cooling L. Transfusion-related acute lung injury. JAMA 2002, 288(3):315-316.
30. Toy P., Hollis-Perry K.M., Jun J., et al. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 2004, 44(12):1683-1688.
31. Kelher M.R., Masuno T., Moore E.E., et al. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood 2009, 113(9):2079-2087.
32. Silliman C.C., Boshkov L.K., Mehdizadehkashi Z., et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003, 101(2):454-462.
33. Muniz M., Sheldon S., Schuller R.M., et al. Patient-specific transfusion-related acute lung injury. Vox Sang 2008, 94(1):70-73.
34. Blennerhassett J.B. Shock lung and diffuse alveolar damage pathological and pathogenetic considerations. Pathology 1985, 17(2):239-247.
35. Moss M., Guidot D.M., Wong-Lambertina M., et al. The effects of chronic alcohol abuse on pulmonary glutathione homeostasis. Am J Respir Crit Care Med 2000, 161(2 Pt 1):414-419.
36. Boe D.M., Richens T.R., Horstmann S.A., et al. Acute and chronic alcohol exposure impair the phagocytosis of apoptotic cells and enhance the pulmonary inflammatory response. Alcohol Clin Exp Res 2010, 34:1723-1732.
37. Wiedemann H.P., Wheeler A.P., Bernard G.R., et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006, 354(24):2564-2575.
38. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000, 342(18):1301-1308.
39. Iribarren C., Jacobs D.R., Sidney S., et al. Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting. Chest 2000, 117(1):163-168.
40. Calfee C.S., Matthay M.A., Eisner M.D., et al. Active and passive cigarette smoking and acute lung injury after severe blunt trauma. Am J Respir Crit Care Med 2011, 183(12):1660-1665.
41. Parsons P.E., Eisner M.D., Thompson B.T., et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005, 33(1):1-6. [discussion: 230-2].
42. Gosselin E.J., Wardwell K., Rigby W.F., et al. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol 1993, 151(3):1482-1490.
43. Geppert T.D., Lipsky P.E. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. J Immunol 1985, 135(6):3750-3762.
44. Kopko P.M., Paglieroni T.G., Popovsky M.A., et al. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion 2003, 43(2):177-184.
45. Yost C.S., Matthay M.A., Gropper M.A. Etiology of acute pulmonary edema during liver transplantation: a series of cases with analysis of the edema fluid. Chest 2001, 119(1):219-223.
46. Looney M.R., Gropper M.A., Matthay M.A. Transfusion-related acute lung injury: a review. Chest 2004, 126(1):249-258.
47. Lee A.J., Koyyalamudi P.L., Martinez-Ruiz R. Severe transfusion-related acute lung injury managed with extracorporeal membrane oxygenation (ECMO) in an obstetric patient. J Clin Anesth 2008, 20(7):549-552.
48. Kuroda H., Masuda Y., Imaizumi H., et al. Successful extracorporeal membranous oxygenation for a patient with life-threatening transfusion-related acute lung injury. J Anesth 2009, 23(3):424-426.
49. Eder A., Herron R., Strupp A., et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007, 47(4):599-607.
50. SHOT Annual Reports and Summaries (All). SHOT 2010 Accessed August 6, 2011. http://www.shotuk.org/wp-content/uploads/2011/07/SHOT-2010-Report1.pdf.
51. Eder A.F., Herron R.M., Strupp A., et al. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion 2010, 50(8):1732-1742.
52. Transfusion-related acute lung injury. AABB Association Bulletin 2006 Accessed February 2, 2011. http://www.aabb.org/Content/Members_Area/Association_Bulletins/ab06-07.htm.
53. Clarifications to recommendations to reduce the risk of TRALI. AABB Association Bulletin 2007 Accessed February 2, 2011. http://www.aabb.org/Content/Members_Area/Association_Bulletins/ab07-03.htm.
54. Carrick D.M., Norris P.J., Endres R.O., et al. Establishing assay cutoffs for HLA antibody screening of apheresis donors. Transfusion 2011, 51(10):2092-2101.